These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
529 related articles for article (PubMed ID: 26874514)
1. Use of deferasirox, an iron chelator, to overcome imatinib resistance of chronic myeloid leukemia cells. Kim DS; Na YJ; Kang MH; Yoon SY; Choi CW Korean J Intern Med; 2016 Mar; 31(2):357-66. PubMed ID: 26874514 [TBL] [Abstract][Full Text] [Related]
2. A molecular and biophysical comparison of macromolecular changes in imatinib-sensitive and imatinib-resistant K562 cells exposed to ponatinib. Yandim MK; Ceylan C; Elmas E; Baran Y Tumour Biol; 2016 Feb; 37(2):2365-78. PubMed ID: 26373734 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of the dual PI3K and mTOR inhibitor NVP-BEZ235 in combination with imatinib mesylate against chronic myelogenous leukemia cell lines. Xin P; Li C; Zheng Y; Peng Q; Xiao H; Huang Y; Zhu X Drug Des Devel Ther; 2017; 11():1115-1126. PubMed ID: 28435223 [TBL] [Abstract][Full Text] [Related]
4. PBA2, a novel inhibitor of imatinib-resistant BCR-ABL T315I mutation in chronic myeloid leukemia. Gupta P; Kathawala RJ; Wei L; Wang F; Wang X; Druker BJ; Fu LW; Chen ZS Cancer Lett; 2016 Dec; 383(2):220-229. PubMed ID: 27720778 [TBL] [Abstract][Full Text] [Related]
5. Targeting Hedgehog signaling pathway and autophagy overcomes drug resistance of BCR-ABL-positive chronic myeloid leukemia. Zeng X; Zhao H; Li Y; Fan J; Sun Y; Wang S; Wang Z; Song P; Ju D Autophagy; 2015; 11(2):355-72. PubMed ID: 25701353 [TBL] [Abstract][Full Text] [Related]
6. The antiproliferation effect of berbamine on k562 resistant cells by inhibiting NF-kappaB pathway. Wei YL; Liang Y; Xu L; Zhao XY Anat Rec (Hoboken); 2009 Jul; 292(7):945-50. PubMed ID: 19548306 [TBL] [Abstract][Full Text] [Related]
8. Targeting HSPA8 inhibits proliferation via downregulating BCR-ABL and enhances chemosensitivity in imatinib-resistant chronic myeloid leukemia cells. Liu Z; Zheng W; Liu Y; Zhou B; Zhang Y; Wang F Exp Cell Res; 2021 Aug; 405(2):112708. PubMed ID: 34157313 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of protein kinase CK2 by CX-5011 counteracts imatinib-resistance preventing rpS6 phosphorylation in chronic myeloid leukaemia cells: new combined therapeutic strategies. Salizzato V; Borgo C; Cesaro L; Pinna LA; Donella-Deana A Oncotarget; 2016 Apr; 7(14):18204-18. PubMed ID: 26919095 [TBL] [Abstract][Full Text] [Related]
10. Blockade of the interaction between Bcr-Abl and PTB1B by small molecule SBF-1 to overcome imatinib-resistance of chronic myeloid leukemia cells. Elgehama A; Chen W; Pang J; Mi S; Li J; Guo W; Wang X; Gao J; Yu B; Shen Y; Xu Q Cancer Lett; 2016 Mar; 372(1):82-8. PubMed ID: 26721204 [TBL] [Abstract][Full Text] [Related]
11. Idelalisib induces G1 arrest and apoptosis in chronic myeloid leukemia K562 cells. Chen Y; Zhou Q; Zhang L; Wang R; Jin M; Qiu Y; Kong D Oncol Rep; 2016 Dec; 36(6):3643-3650. PubMed ID: 27748929 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of Deng Y; Li X; Feng J; Zhang X Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29559564 [TBL] [Abstract][Full Text] [Related]
13. 4-methylumbelliferone and imatinib combination enhances senescence induction in chronic myeloid leukemia cell lines. Lompardía SL; Díaz M; Papademetrio DL; Pibuel M; Álvarez É; Hajos SE Invest New Drugs; 2017 Feb; 35(1):1-10. PubMed ID: 27718039 [TBL] [Abstract][Full Text] [Related]
14. CM363, a novel naphthoquinone derivative which acts as multikinase modulator and overcomes imatinib resistance in chronic myelogenous leukemia. Guerra B; Martín-Rodríguez P; Díaz-Chico JC; McNaughton-Smith G; Jiménez-Alonso S; Hueso-Falcón I; Montero JC; Blanco R; León J; Rodríguez-González G; Estévez-Braun A; Pandiella A; Díaz-Chico BN; Fernández-Pérez L Oncotarget; 2017 May; 8(18):29679-29698. PubMed ID: 27557509 [TBL] [Abstract][Full Text] [Related]
15. CD-200 induces apoptosis and inhibits Bcr-Abl signaling in imatinib-resistant chronic myeloid leukemia with T315I mutation. Fang Z; Jung KH; Yan HH; Kim SJ; Son MK; Rumman M; Lee H; Kim KW; Yoo HD; Hong SS Int J Oncol; 2015 Jul; 47(1):253-61. PubMed ID: 25963192 [TBL] [Abstract][Full Text] [Related]
16. A novel tubulin polymerization inhibitor, MPT0B206, downregulates Bcr-Abl expression and induces apoptosis in imatinib-sensitive and imatinib-resistant CML cells. Chen CW; Lee YL; Liou JP; Liu YH; Liu CW; Chen TY; Huang HM Apoptosis; 2016 Sep; 21(9):1008-18. PubMed ID: 27344662 [TBL] [Abstract][Full Text] [Related]
17. Hsp90 inhibitor, BIIB021, induces apoptosis and autophagy by regulating mTOR-Ulk1 pathway in imatinib-sensitive and -resistant chronic myeloid leukemia cells. He W; Ye X; Huang X; Lel W; You L; Wang L; Chen X; Qian W Int J Oncol; 2016 Apr; 48(4):1710-20. PubMed ID: 26892093 [TBL] [Abstract][Full Text] [Related]
18. HS-543 induces apoptosis of Imatinib-resistant chronic myelogenous leukemia with T315I mutation. Kim SJ; Jung KH; Yan HH; Son MK; Fang Z; Ryu YL; Lee H; Lim JH; Suh JK; Kim J; Lee S; Hong S; Hong SS Oncotarget; 2015 Jan; 6(3):1507-18. PubMed ID: 25483100 [TBL] [Abstract][Full Text] [Related]
19. Sensitivity of imatinib-resistant T315I BCR-ABL CML to a synergistic combination of ponatinib and forskolin treatment. Oaxaca DM; Yang-Reid SA; Ross JA; Rodriguez G; Staniswalis JG; Kirken RA Tumour Biol; 2016 Sep; 37(9):12643-12654. PubMed ID: 27444277 [TBL] [Abstract][Full Text] [Related]
20. Cryptotanshinone acts synergistically with imatinib to induce apoptosis of human chronic myeloid leukemia cells. Ge Y; Yang B; Xu X; Dai Q; Chen Z; Cheng R Leuk Lymphoma; 2015 Mar; 56(3):730-8. PubMed ID: 24884318 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]